GlassScriptPhysician profile
Carmen Ng
NPI 1073288015
$2,687.63
in general payments reported to CMS, 2019-2025
18 companies · $1,130 in 2025
The $1,130 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $223 · 2023: $178 · 2024: $1,156 · 2025: $1,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,388 · Education: $76.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,387.60 |
| Education | $76.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $373.75 | 2025 | Bylvay, Iqirvo |
| Madrigal Pharmaceuticals | $268.06 | 2024-2025 | Rezdiffra |
| Kyowa Kirin, INC. | $245.53 | 2024 | Crysvita |
| Janssen Biotech, INC. | $199.05 | 2024-2025 | Tremfya, Stelara |
| Mirum Pharmaceuticals, INC. | $149.98 | 2025 | Livmarli |
| Boston Scientific Corporation | $143.46 | 2025 | Ams 700 |
| Janssen Pharmaceuticals, INC | $137.86 | 2024 | Spravato |
| Sumitomo Pharma America, INC. | $124.99 | 2023 | Gemtesa |
| Gilead Sciences, INC. | $124.99 | 2024 | Livdelzi |
| Aimmune Therapeutics, INC. | $121.82 | 2025 | Zenpep |
| Abbvie INC. | $116.71 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $114.14 | 2025 | Austedo Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $113.52 | 2022 | |
| Evoke Pharma, INC. | $112.04 | 2024 | |
| Si-Bone, INC. | $109.52 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $97.44 | 2024 | Daybue |
| Pfizer INC. | $81.40 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.